Related Experiment Video
Updated: Aug 7, 2026

09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
A new view on cutaneous dendritic cell subsets in experimental leishmaniasis
1Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Strasse 74, 20359 Hamburg, Germany. ritter@bni-hamburg.de
Medical Microbiology and Immunology
|June 21, 2006
Summary
Epidermal Langerhans cells (LCs) may not be the primary activators of T cell immunity as previously thought. Research using leishmaniasis models suggests a revised understanding of LC roles in cutaneous immune responses.
Area of Science:
- Immunology
- Dermatology
- Cell Biology
Background:
- Epidermal Langerhans cells (LCs) are anatomically positioned for antigen uptake and presentation in skin-draining lymph nodes.
- LCs were traditionally considered crucial for initiating T cell responses in the skin.
- Recent studies challenge the established role of LCs as primary T cell activators.
Purpose of the Study:
- To revisit the biological role of epidermal Langerhans cells (LCs) in cutaneous immune responses.
- To investigate the function of LCs in T cell-mediated immunity using the leishmaniasis model.
- To propose a novel concept for LC involvement in immunity against Leishmania major parasites.
Main Methods:
- Utilizing LC-specific markers (e.g., Langerin) and knock-in mouse models for LC isolation.
- Employing the leishmaniasis experimental model to study antigen-specific T cell responses.
- Monitoring the transport and presentation of Leishmania (L.) major antigens in vivo.
- Assessing the quality of T cell-dendritic cell (DC) interactions.
Main Results:
- Current data suggest LCs are not universally involved in inducing cellular immune responses.
- The paradigm of LCs as principal T cell activators is being questioned by recent publications.
- The leishmaniasis model allows in vivo monitoring of antigen presentation and T cell-DC interactions.
Conclusions:
- The established role of epidermal Langerhans cells (LCs) in T cell activation requires re-evaluation.
- A novel concept regarding the function of LCs in T cell-mediated immunity against Leishmania major is proposed.
- Further research is needed to fully elucidate the complex role of LCs in cutaneous immunity.
Related Concept Videos
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...